retatrutide weight loss clinical data 💉 may be redefining obesity treatment. New from TRIUMPH-1 Trial showed: 🔥 ~28% average over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic What the clinical trials say

The rate at which appetite suppression occurs can vary from person to person, depending on factors such as your starting dose, how quickly your dose is adjusted, and your unique response to the medication

Consistent moderate deficits produce better long-term outcomes than alternating between very low intake and compensatory eating

The main question has changed from whether Novo Nordisks growth will continue with obesity treatments to how well the business can scale up manufacturing to meet rising worldwide demand in a market that is becoming more competitive

That is starting to change

Activated CD8 + T cells inhibit ferroptosis by binding to TYRO3 and promote the development of a pro-tumor microenvironment by decreasing the M1/M2 macrophage ratio, leading to resistance to anti-PD-1/PD-L1 therapy (255)

While still more pronounced than pre weight loss, my nasolabial folds were definitely not as deep, while my jawline looked in better nick too